We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+20.97%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$2.51B
AUM Growth
+$287M
Cap. Flow
+$70.5M
Cap. Flow %
2.8%
Top 10 Hldgs %
85.06%
Holding
41
New
2
Increased
6
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$60.2M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$47.5M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$8.15M
4
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$4.97M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$4.89M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$33.8M
2
NVRO
NEVRO CORP.
NVRO
+$25.7M
3
XCOM
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
+$2M
4
HIVE
Aerohive Networks
HIVE
+$43.8K
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$6

Sector Composition

Rank Sector Weight
1 Healthcare 94.84%
2 Communication Services 2.65%
3 Technology 1.4%
4 Consumer Discretionary 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
26
DELISTED
Synlogic
SYBX
$5.36M 0.21%
28,332
– –
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$4.7M 0.19%
956,258
– –
VIRX
28
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.7M 0.19%
37,094
– –
ORKA
29
Oruka Therapeutics
ORKA
$6.1B
$4.16M 0.17%
6,760
– –
CSBR icon
30
Champions Oncology
CSBR
$66.4M
$3.95M 0.16%
1,562,500
– –
ROKA
31
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$3.79M 0.15%
893,471
+571,428
+177% +$2.88M
AKTX
32
Akari Therapeutics
AKTX
$20M
$3.18M 0.13%
565
– –
ARQL
33
DELISTED
Arqule Inc
ARQL
$3.18M 0.13%
2,520,316
– –
ZSAN
34
DELISTED
Zosano Pharma Corporation
ZSAN
$1.6M 0.06%
2,933
– –
PRTK
35
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.02M 0.04%
66,245
– –
AGRX
36
DELISTED
Agile Therapeutics
AGRX
$761K 0.03%
67
– –
OREX
37
DELISTED
Orexigen Therapeutics, Inc.
OREX
$645K 0.03%
370,900
– –
AVTX icon
38
Avalo Therapeutics
AVTX
$862M
$524K 0.02%
207
– –
GYRE icon
39
Gyre Therapeutics
GYRE
$709M
$424K 0.02%
5,799
– –
LOXO
40
DELISTED
Loxo Oncology, Inc
LOXO
– –
-1,289,420
Closed -$33.8M
XCOM
41
DELISTED
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
– –
-3,631,537
Closed -$2M
1
2

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q4 2016 Portfolio in Review

As of Q4 2016, NEA Management Company held 41 positions worth $2.51B, up 13% from $2.23B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

NEA Management Company's Q4 2016 filing shows 2 new, 6 increased, 3 reduced and 2 closed positions. Its largest new stake was CRISPR Therapeutics: 3,220,728 shares worth $65.3M. The largest sale was Loxo Oncology, Inc, an estimated $33.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Communication Services and Technology.

  • NEA Management Company's largest Q4 2016 buy was CRISPR Therapeutics: 3,220,728 shares worth $65.3M.
  • NEA Management Company added most to Strongbridge Biopharma plc. in Q4 2016, an estimated $8.15M increase.
  • NEA Management Company's biggest Q4 2016 reduction was NEVRO CORP., cutting an estimated $25.7M.
  • NEA Management Company fully exited Loxo Oncology, Inc in Q4 2016, selling an estimated $33.8M.
  • NEA Management Company's ten largest holdings make up 85% of its $2.51B portfolio in Q4 2016.
  • NEA Management Company opened 2 new positions and closed 2 in Q4 2016.
  • NEA Management Company's portfolio value rose 13% quarter-over-quarter to $2.51B.

Based on NEA Management Company's 13F filing for Q4 2016, filed 9 Feb 2017.